Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma

Name: Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma
Published: 2007
License: Public Domain

Amgen · 2007

ClinicalTrials.gov · Datasets · License: Public Domain · 2007

Open Source ↗

apoptosis soft-tissue-sarcoma

locally advanced or metastatic, unresectable soft tissue sarcoma, sarcoma, soft tissue sarcoma, amg 655, sts, doxorubicin, death receptor, trail receptor, apoptosis, interventional, phase1, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma

Related documents